Spots Global Cancer Trial Database for Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
Official Title: Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer：a Randomized Controlled Study
Study ID: NCT05633199
Conditions
Interventions
Study Description
Brief Summary: This novel study was specifically designed for platinum-resistant recurrent ovarian cancers with PFI\<6 months and aimed to compare prognosis of patients who received cytoreductive surgery followed by chemotherapy versus chemotherapy alone.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Women's Hospital, Zhejiang University School of Medicine, Hangzhou, , China
Women's Hospital, Zhejiang University School of Medicine, Hangzhou, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
